Study title:
Leuk Lymphoma. 2004 Jan;45(1):85-92.
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the
follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison.
Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM,
Canellos GP, van den Abbeele AD.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|